Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (ME 1303 5785)
Received: 30 January 2019
Accepted: 16 July 2019
First Online: 5 September 2019
Ethics approval and consent to participate
: The study received an exemption from the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (IRB No: 00006324).
: Not applicable.
: Up to 2008, KD served as an unpaid expert witness for Greene LLP, the plaintiffs’ lawyers in litigation against Pfizer that provided several gabapentin documents used for this study. Swaroop Vedula was paid by the plaintiffs’ attorneys for research assistance provided to KD for her work as an expert witness. Greene LLP provided a fund for scholarly research on reporting biases that provided salary support for NF and EMW.